SMTL ID : 6vxq.1

Bruton's tyrosine kinase in complex with compound 5

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.40 Å

Oligo State

monomer

Ligands

2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.1: 4 residues within 4Å: Chain A: R.196, M.230, E.233, F.235 No protein-ligand interaction detected (PLIP) DMS.3: 3 residues within 4Å: Chain A: Y.261, T.262, Y.265 No protein-ligand interaction detected (PLIP)

1 x RQS: N-{[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]methyl}benzamide(Non-covalent)

RQS.2: 13 residues within 4Å: Chain A: L.42, G.45, V.50, A.62, K.64, E.109, Y.110, M.111, G.114, N.160, L.162, D.173, L.176 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.42, A:V.50, A:V.50, A:D.173, A:L.176 Hydrogen bonds: A:M.111, A:M.111 Water bridges: A:G.45

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ma, B. et al., Discovery of BIIB068: A Selective, Potent, Reversible Bruton's Tyrosine Kinase Inhibitor as an Orally Efficacious Agent for Autoimmune Diseases. J.Med.Chem. (2020)

Release Date

2020-12-16

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence